BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 26366800)

  • 1. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
    Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M
    Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Cervigni M
    Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
    Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erbium laser in gynecology: aims, aspirations and action points.
    Gambacciani M; Cervigni M
    Climacteric; 2015; 18 Suppl 1():2-3. PubMed ID: 26366792
    [No Abstract]   [Full Text] [Related]  

  • 5. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M
    Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.
    Gambacciani M; Levancini M
    Menopause; 2017 Mar; 24(3):316-319. PubMed ID: 28231079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study.
    Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z
    Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser therapy for the restoration of vaginal function.
    Gambacciani M; Palacios S
    Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study.
    Gambacciani M; Albertin E; Torelli MG; Bracco GL; Casagrande AC; Martella L; Baiocchi G; Alfieri S; Russo N; Cervigni M;
    Climacteric; 2020; 23(sup1):S24-S27. PubMed ID: 33124454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser Therapy for Genitourinary Syndrome of Menopause.
    Rabley A; O'Shea T; Terry R; Byun S; Louis Moy M
    Curr Urol Rep; 2018 Aug; 19(10):83. PubMed ID: 30117032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erbium laser in gynecology.
    Vizintin Z; Lukac M; Kazic M; Tettamanti M
    Climacteric; 2015; 18 Suppl 1():4-8. PubMed ID: 26366793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of intraurethral Erbium:YAG laser treatment in women with stress urinary incontinence following failed intravaginal laser therapy: a retrospective study.
    Tseng YL; Su CF
    Lasers Med Sci; 2023 Sep; 38(1):207. PubMed ID: 37688606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genitourinary syndrome of menopause (GSM) and laser VEL: a review.
    Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
    Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study.
    Moral E; Delgado JL; Carmona F; Caballero B; Guillán C; González PM; Suárez-Almarza J; Velasco-Ortega S; Nieto C;
    Climacteric; 2018 Apr; 21(2):167-173. PubMed ID: 29411644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Jha S; Wyld L; Krishnaswamy PH
    Clin Breast Cancer; 2019 Aug; 19(4):e556-e562. PubMed ID: 31227415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female urine incontinence:
    Elia D; Gambiacciani M; Ayoubi JM; Berreni N; Bohbot JM; Descamps P; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
    Horm Mol Biol Clin Investig; 2020 Oct; 41(4):. PubMed ID: 33119542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
    Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
    Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause.
    Gaspar A; Brandi H; Gomez V; Luque D
    Lasers Surg Med; 2017 Feb; 49(2):160-168. PubMed ID: 27546524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. At-Home Transvaginal Device Following Fractional Carbon Dioxide Laser Treatment for Genitourinary Syndrome of Menopause.
    Alexiades M
    J Drugs Dermatol; 2020 Nov; 19(11):1076-1079. PubMed ID: 33196757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.